Novel indole derivatives of formula (I) or a pharmaceutically acceptable salt thereof:
wherein R
1
is fluorine, or chlorine, and R
2
is hydrogen, or fluorine, which are SGLT inhibitors and are useful for treatment or prevention of diabetes and related conditions.